Zeb2-overexpressing thymic tumours lack mature T-cell markers such as surface CD3 and CD8 and exhibited a higher percentage of cells that expressed the stem/progenitor marker cKit or CD44, when compared with the control P53/R26+/+-deficient tumours (Fig. 3c). Here, ZEB2 is linked to neoplasm.